Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
6 pending office actions • 3 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 12 patents granted in the last 365 days
Guangdong Aglaia Optoelectronic Materials Co. Ltd. has 6 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 6 actions are distributed among 6 distinct examiners, meaning every pending matter is being reviewed by a different individual. These actions are further organized into 3 distinct art units, suggesting that the examiners are grouped into separate supervisory environments within the USPTO.
The busiest examiner, OTTON, ALICIA L, is responsible for 1 pending office action. Because the busiest examiner handles only 1 of the total pending actions, the portfolio shows no examiner concentration. This requires the company to manage 6 distinct examiner relationships. However, the 3 distinct art units indicate that the pending matters are likely related to specific technical sub-fields, which may allow for some consistency in prosecution strategy within each unit. The current workload represents a set of reviews across the biotechnology and pharmaceutical sectors handled by the assigned staff.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (17%) |
| §102 only | 1 (17%) |
| §112 only | 2 (33%) |
| Multi-statute (no §101) | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| OTTON, ALICIA L | 1 | 64.9% | +9.4% |
| HAVLIN, ROBERT H | 1 | 51.5% | +28.1% |
| GARRETT, DAWN L | 1 | 72.6% | +10.3% |
| YANG, JAY LEE | 1 | 73.9% | +2.0% |
| DEGUIRE, SEAN M | 1 | 60.7% | +28.7% |
| MCDOWELL, BRIAN E | 1 | 74.1% | +30.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18562205 | ORGANIC ELECTROLUMINESCENT MATERIALS CONTAINING B-N FUSED RINGS, AND APPLICATIONS THEREOF | HAVLIN, ROBERT H | — |
| 18562177 | HETEROCYCLIC MODIFIED PLATINUM COMPLEX CONTAINING ONCN TETRADENTATE LIGAND | GARRETT, DAWN L | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17777027 | IMIDAZOPYRIDINE-BASED ARYLAMINE COMPOUND AND USE THEREOF | MCDOWELL, BRIAN E | 28d overdue |
| 18562205 | ORGANIC ELECTROLUMINESCENT MATERIALS CONTAINING B-N FUSED RINGS, AND APPLICATIONS THEREOF | HAVLIN, ROBERT H | — |
| 18562177 | HETEROCYCLIC MODIFIED PLATINUM COMPLEX CONTAINING ONCN TETRADENTATE LIGAND | GARRETT, DAWN L | — |
| 17926969 | ONCN QUADRIDENTATE LIGAND-CONTAINING PLATINUM COMPLEX AND APPLICATION THEREOF IN ORGANIC LIGHT-EMITTING DIODE | DEGUIRE, SEAN M | — |
| Art Unit | Apps |
|---|---|
| 1626 | 1 |
| 1786 | 1 |
| 1624 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18873893 | ORGANIC ELECTROLUMINESCENT MATERIAL AND USE THEREOF | OTTON, ALICIA L | — | §102 | Non-Final OA | — | Pending | Dec 11, 2024 |
| 18562205 | ORGANIC ELECTROLUMINESCENT MATERIALS CONTAINING B-N FUSED RINGS, AND APPLICATIONS THEREOF | HAVLIN, ROBERT H | 1626 | §102§112 | Non-Final OA | — | Pending | Nov 17, 2023 |
| 18562177 | HETEROCYCLIC MODIFIED PLATINUM COMPLEX CONTAINING ONCN TETRADENTATE LIGAND | GARRETT, DAWN L | — | §103§112 | Non-Final OA | — | Pending | Nov 17, 2023 |
| 18038679 | DIVALENT PLATINUM COMPLEX | YANG, JAY LEE | — | §112 | Non-Final OA | — | Pending | May 24, 2023 |
| 17926969 | ONCN QUADRIDENTATE LIGAND-CONTAINING PLATINUM COMPLEX AND APPLICATION THEREOF IN ORGANIC LIGHT-EMITTING DIODE | DEGUIRE, SEAN M | 1786 | §103 | Non-Final OA | — | Pending | Nov 21, 2022 |
| 17777027 | IMIDAZOPYRIDINE-BASED ARYLAMINE COMPOUND AND USE THEREOF | MCDOWELL, BRIAN E | 1624 | §112 | Non-Final OA | 28d overdue | Pending | May 14, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial